Long-term parenteral nutrition in pediatric autoimmune enteropathies. 2005

M Gambarara, and F Bracci, and A Diamanti, and M I Ambrosini, and A Pietrobattista, and D Knafelz, and F Ferretti, and M Castro
Gastroenterology and Nutrition Unit, Bambino Gesu Children Hospital, Piazza S. Onofrio 4, Rome RM 00174, Italy.

Severe and protracted or persistent diarrhea (SPD) is the most severe form of diarrhea in infancy and has also been defined as intractable diarrhea when it leads to dependence on total parenteral nutrition (TPN). One of the rare causes of SPD is represented by autoimmune enteropathy that is characterized by life-threatening diarrhea mainly occurring within the first years of life, persistent villous atrophy in consecutive biopsies, resistance to bowel rest, and evidence of antigut autoantibodies. We evaluated 10 patients (seven boys, mean age at diagnosis 18 months; range: 0 to 160 months) fulfilling criteria of autoimmune enteropathy to assess dependence on TPN. TPN was first required in all patients to avoid dehydration and electrolytic imbalance. All patients were dependent on immunosuppressive therapy (steroid, azothioprine, cyclosporine, tacrolimus). Three patients died of sepsis: two during TPN while in the hospital, and one at home after he was weaned off TPN. Five patients are weaned off TPN after a mean period of 18 months; they are actually on oral alimentation with a cow milk-free diet after a period of enteral nutrition with elemental formula. One underwent total colectomy and bone marrow transplantation and one developed an IPEX syndrome. One patient is still dependent on TPN for 24 months. She is on home parenteral nutrition. Patients with diagnosis of IPEX syndrome require parenteral support with three or four infusion per week. TPN represents a fixed step in the management of autoimmune enteropathy, but it may be considered as an interim treatment while waiting for intestinal adaptation, at least in some selectioned case of autoimmune enteropathy. Bone marrow transplantation should be considered and reserved for those patients with severe complications due to home parenteral nutrition, or in those that are really dependent on parenteral nutrition.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D010288 Parenteral Nutrition The administering of nutrients for assimilation and utilization by a patient who cannot maintain adequate nutrition by enteral feeding alone. Nutrients are administered by a route other than the alimentary canal (e.g., intravenously, subcutaneously). Intravenous Feeding,Nutrition, Parenteral,Parenteral Feeding,Feeding, Intravenous,Feeding, Parenteral,Feedings, Intravenous,Feedings, Parenteral,Intravenous Feedings,Parenteral Feedings
D011504 Protein-Losing Enteropathies Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE. Enteropathy, Exudative,Idiopathic Hypercatabolic Hypoproteinemia,Enteropathy, Protein-Losing,Protein-Losing Enteropathy,Enteropathies, Exudative,Enteropathies, Protein-Losing,Exudative Enteropathies,Exudative Enteropathy,Hypercatabolic Hypoproteinemia, Idiopathic,Hypercatabolic Hypoproteinemias, Idiopathic,Hypoproteinemia, Idiopathic Hypercatabolic,Hypoproteinemias, Idiopathic Hypercatabolic,Idiopathic Hypercatabolic Hypoproteinemias,Protein Losing Enteropathies,Protein Losing Enteropathy
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

M Gambarara, and F Bracci, and A Diamanti, and M I Ambrosini, and A Pietrobattista, and D Knafelz, and F Ferretti, and M Castro
September 1998, Transplantation proceedings,
M Gambarara, and F Bracci, and A Diamanti, and M I Ambrosini, and A Pietrobattista, and D Knafelz, and F Ferretti, and M Castro
June 1994, Transplantation proceedings,
M Gambarara, and F Bracci, and A Diamanti, and M I Ambrosini, and A Pietrobattista, and D Knafelz, and F Ferretti, and M Castro
March 2024, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
M Gambarara, and F Bracci, and A Diamanti, and M I Ambrosini, and A Pietrobattista, and D Knafelz, and F Ferretti, and M Castro
July 1978, British medical journal,
M Gambarara, and F Bracci, and A Diamanti, and M I Ambrosini, and A Pietrobattista, and D Knafelz, and F Ferretti, and M Castro
April 1979, British medical journal,
M Gambarara, and F Bracci, and A Diamanti, and M I Ambrosini, and A Pietrobattista, and D Knafelz, and F Ferretti, and M Castro
February 1979, British medical journal,
M Gambarara, and F Bracci, and A Diamanti, and M I Ambrosini, and A Pietrobattista, and D Knafelz, and F Ferretti, and M Castro
April 2016, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition,
M Gambarara, and F Bracci, and A Diamanti, and M I Ambrosini, and A Pietrobattista, and D Knafelz, and F Ferretti, and M Castro
February 2020, JPEN. Journal of parenteral and enteral nutrition,
M Gambarara, and F Bracci, and A Diamanti, and M I Ambrosini, and A Pietrobattista, and D Knafelz, and F Ferretti, and M Castro
February 1975, Indian pediatrics,
M Gambarara, and F Bracci, and A Diamanti, and M I Ambrosini, and A Pietrobattista, and D Knafelz, and F Ferretti, and M Castro
July 2015, JPEN. Journal of parenteral and enteral nutrition,
Copied contents to your clipboard!